IL makes direct impact on Hemostasis line
It’s not always doom and gloom in the med-tech industry. Some med-tech companies are making significant strides, and it doesn’t always revolve around garnering a significant funding or getting FDA approval on a product.
Awarding an Oscar for best performance in raising awareness of prosthetic technologies
![thumbnail[9]](http://mdd.blogs.medicaldevicedaily.com/files/2012/08/thumbnail92-150x150.jpg)
Oscar Pistorius didn’t win a medal in the just-concluded Olympic Games. Not a gold, not a silver, not a bronze. In fact, he finished last in his semifinal heat of the 400-meter run (I think they call it the 400-meter…
The implications of cloud-based solutions in healthcare
![cloud_0[1]](http://mdd.blogs.medicaldevicedaily.com/files/2012/08/cloud_011-150x150.jpg)
By Steve Deaton MDD Perspectives Contributing Writer
FDA misconduct not deemed newsworthy
By Kelly Roman, Vice President of Fisher Wallace Labs On February 10, 2012, the FDA convened an advisory panel hearing on whether to reclassify cranial electrotherapy stimulation (CES) devices. Despite being a low-risk device, CES has lingered in Class 3…
On This Date in History: Medicare signed into law in 1965
At the risk of becoming mired in the past, we are inclined to glance backward now and then to see where we’ve been and ask what the past says about where we’re going. So let’s examine July 30, 1965, the…
Myriad at CAFC: Three points to remember
The July 20 hearing at the Court of Appeals for the Federal Circuit addressing the Myriad case did not last a terribly long time, but there were a few object lessons to take away. We last visited this situation shortly…
No excuses, get an EHR!
An acquaintance of mine who, like me, has inflammatory bowel disease, received a call recently from her local hospital informing her they had lost her MRI images. They found them, but she is concerned they will have to retake them…
FDA whistleblower story resurfaces
Well, God forbid people in my line of work should run out of things to be outraged about, but the saga of the FDA whistleblowers has boiled over again.
IBD: an equal-opportunity disease!
Crohn’s and Ulcerative Colitis, known collectively as inflammatory bowel disease (IBD), do not discriminate between age, race, gender, economic status, or geographic borders. It is truly an equal-opportunity disease!
Living with a pain in the rear
I am living with a pain in the rear. Casey Abrams, a musician and American Idol alumnus, would say I am living with a “chip on my shoulder,” but I prefer to be as literal as possible. So yes, I…
